Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Market Cap
$45.14M
P/E Ratio
-0.54
1Y Stock Return
-72.88%
1Y Revenue Growth
187.45%
Dividend Yield
0.00%
Price to Book
-1.3
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
WEST CHESTER, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the pricing of an underwritten public offering of 44,964,045 shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 2,235,955 shares of its common stock, and in either case, acco
Yahoo
WEST CHESTER, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof) and in either case, accompanying warrants to purchase shares of its common stock, in an underwritten public offering.
Yahoo
– Company reported $0 in product shipments in the third quarter of 2024 and recognized negative net product revenue of $1.9 million, including a provision for product returns of $1.7 million– – Company expects existing distributor inventory to support most demand for dispensed applicator units into the first quarter of 2025 – – Company continues to look for ways to manage expenses and expand access to YCANTH® for the treatment of molluscum contagiosum – – Company announces new senior leadership
Finnhub
Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition - Company reported $0 in product shipments in the...
Finnhub
SAN FRANCISCO, Oct. 30, 2024 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Verrica Pharmaceuticals Inc. investors that the firm is investigating potential legal claims relating to the...
Yahoo
- Posters to highlight the safety data, tolerability data, and antitumor efficacy data of VP-315 for the treatment of basal cell carcinoma as determined by histological clearance - WEST CHESTER, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the acceptance of two abstracts that will be presented as posters a
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CNSL | <0.01% | $548.51M | +9.72% | 0.00% |
SF | 0.01% | $11.77B | +86.13% | 1.41% |
REAL | -0.01% | $491.42M | +99.55% | 0.00% |
EQNR | 0.01% | $68.06B | -17.66% | 5.52% |
ACDC | -0.01% | $1.21B | -9.47% | 0.00% |
VLO | 0.02% | $44.67B | +12.56% | 3.04% |
EDSA | -0.03% | $6.85M | -33.28% | 0.00% |
PRU | -0.03% | $44.95B | +32.74% | 4.10% |
EQC | -0.04% | $2.16B | +5.19% | 0.00% |
MSGS | -0.04% | $5.48B | +33.42% | 0.00% |
LPX | -0.04% | $8.04B | +86.84% | 0.91% |
NLOP | 0.08% | $459.67M | +97.90% | 0.00% |
BOOT | 0.09% | $4.16B | +91.77% | 0.00% |
SRPT | 0.10% | $10.55B | +31.91% | 0.00% |
ATMU | -0.12% | $3.64B | +102.08% | 0.23% |
EIX | 0.12% | $33.72B | +32.15% | 3.56% |
HMST | 0.12% | $212.90M | +85.39% | 0.00% |
TD | 0.13% | $97.71B | -8.24% | 5.36% |
AXP | 0.13% | $206.40B | +78.89% | 0.92% |
UNH | 0.13% | $549.86B | +9.88% | 1.34% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AADI | -26.68% | $56.20M | -52.00% | 0.00% |
INGR | -26.44% | $9.41B | +38.47% | 2.18% |
PGR | -21.80% | $154.33B | +62.01% | 0.44% |
UUU | -17.81% | $4.98M | -18.37% | 0.00% |
PPC | -17.59% | $12.39B | +100.88% | 0.00% |
TCTM | -17.21% | $7.57M | -41.30% | 0.00% |
DKL | -16.90% | $2.05B | -19.47% | 10.86% |
CQP | -16.36% | $26.11B | -7.01% | 5.93% |
ARIS | -15.16% | $841.63M | +241.17% | 1.42% |
ACGL | -14.88% | $37.09B | +20.63% | 0.00% |
K | -14.72% | $27.93B | +52.93% | 2.77% |
BRO | -14.46% | $31.67B | +48.58% | 0.48% |
ETR | -14.13% | $32.49B | +49.77% | 3.02% |
LPLA | -13.93% | $24.20B | +42.81% | 0.37% |
ALL | -13.92% | $53.88B | +49.52% | 1.80% |
HCKT | -13.89% | $846.57M | +35.99% | 1.43% |
TRGP | -13.27% | $45.29B | +138.12% | 1.32% |
CAH | -13.24% | $29.87B | +16.57% | 1.63% |
AIFU | -13.23% | $70.89M | -81.83% | 0.00% |
AJG | -12.91% | $66.36B | +20.50% | 0.77% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MQ | 37.74% | $1.99B | -36.33% | 0.00% |
BVN | 37.40% | $3.12B | +34.06% | 0.00% |
DMRC | 34.27% | $672.94M | -3.39% | 0.00% |
OUST | 31.72% | $446.44M | +77.98% | 0.00% |
CERS | 26.38% | $310.14M | +1.21% | 0.00% |
ABCL | 26.33% | $803.40M | -38.60% | 0.00% |
ALT | 26.25% | $597.80M | +228.32% | 0.00% |
DQ | 26.02% | $1.26B | -27.01% | 0.00% |
PLL | 26.00% | $234.22M | -58.10% | 0.00% |
TWST | 25.82% | $2.44B | +74.97% | 0.00% |
RMBL | 25.76% | $219.65M | +2.99% | 0.00% |
AMR | 25.76% | $3.28B | -7.53% | 0.20% |
IDYA | 25.62% | $2.30B | -15.82% | 0.00% |
IPGP | 25.57% | $3.24B | -21.76% | 0.00% |
MGTX | 25.47% | $462.67M | +9.43% | 0.00% |
FSLR | 25.42% | $19.48B | +13.92% | 0.00% |
W | 25.39% | $5.34B | -12.77% | 0.00% |
HOFT | 25.37% | $202.49M | +1.72% | 4.87% |
PBYI | 25.32% | $142.35M | -29.95% | 0.00% |
TITN | 25.27% | $334.66M | -45.60% | 0.00% |
Current Value
$0.981 Year Return
Current Value
$0.981 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBO | 0.03% | $218.38M | 0.77% |
XLE | 0.12% | $38.44B | 0.09% |
XBIL | 0.15% | $637.84M | 0.15% |
IVOL | -0.24% | $549.88M | 1.02% |
XHLF | -0.30% | $883.02M | 0.03% |
USCI | 0.32% | $185.92M | 1.07% |
TBIL | -0.43% | $4.39B | 0.15% |
DRLL | 0.47% | $340.52M | 0.41% |
XLU | 0.61% | $17.27B | 0.09% |
FTXN | 0.66% | $183.18M | 0.6% |
BSCP | 0.90% | $4.04B | 0.1% |
VDE | 0.92% | $8.39B | 0.1% |
BAB | 0.93% | $1.06B | 0.28% |
FENY | 1.05% | $1.64B | 0.084% |
IYE | 1.13% | $1.36B | 0.39% |
ICSH | 1.36% | $5.55B | 0.08% |
EWP | 1.36% | $914.05M | 0.5% |
CANE | 1.38% | $17.43M | 0.29% |
VPU | 1.43% | $6.71B | 0.1% |
FUTY | 1.47% | $1.74B | 0.084% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PBW | 25.32% | $297.98M | 0.65% |
PTH | 24.68% | $141.72M | 0.6% |
ARKG | 24.67% | $1.14B | 0.75% |
IBB | 24.25% | $6.64B | 0.45% |
XBI | 24.20% | $6.75B | 0.35% |
ACES | 23.48% | $120.86M | 0.55% |
QCLN | 23.45% | $585.80M | 0.59% |
ROBT | 23.28% | $449.25M | 0.65% |
GSSC | 23.19% | $533.32M | 0.2% |
CLOU | 23.07% | $351.59M | 0.68% |
SLX | 23.06% | $88.97M | 0.56% |
PSC | 22.85% | $710.79M | 0.38% |
FBT | 22.80% | $1.13B | 0.56% |
XT | 22.75% | $3.41B | 0.46% |
WCLD | 22.42% | $466.53M | 0.45% |
PRNT | 22.42% | $95.94M | 0.66% |
ICVT | 22.40% | $2.54B | 0.2% |
VTWO | 22.37% | $12.48B | 0.1% |
ROBO | 22.35% | $1.06B | 0.95% |
ARKX | 22.32% | $258.71M | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -21.07% | $379.51M | 1.43% |
AGZD | -14.66% | $142.85M | 0.23% |
MNA | -13.13% | $220.86M | 0.77% |
IGBH | -8.78% | $93.80M | 0.14% |
IAK | -8.48% | $755.17M | 0.39% |
USDU | -6.78% | $201.83M | 0.5% |
EMLP | -6.21% | $3.03B | 0.96% |
UUP | -6.16% | $359.07M | 0.77% |
VIXY | -5.91% | $195.31M | 0.85% |
ACWV | -5.70% | $4.26B | 0.2% |
IYK | -5.60% | $1.31B | 0.4% |
EWJV | -5.48% | $258.27M | 0.15% |
AMLP | -5.43% | $9.58B | 0.85% |
IXC | -5.42% | $2.23B | 0.41% |
FTXG | -5.41% | $31.13M | 0.6% |
TPYP | -5.39% | $680.38M | 0.4% |
FXG | -5.36% | $393.78M | 0.63% |
IDU | -5.33% | $1.43B | 0.39% |
SPLV | -5.28% | $7.45B | 0.25% |
KIE | -5.26% | $999.76M | 0.35% |